These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22943600)

  • 1. Systems biology in the frontier of cancer research: a report of the Second International Workshop of Cancer Systems Biology.
    Cui J; Liang YC; Xu Y
    Chin J Cancer; 2012 Sep; 31(9):409-12. PubMed ID: 22943600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Report on the International Workshop 'Cancer stem cells: the mechanisms of radioresistance and biomarker discovery'.
    Dubrovska A
    Int J Radiat Biol; 2014 Aug; 90(8):607-14. PubMed ID: 24844377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The zebrafish as a model for cancer.
    Mione MC; Trede NS
    Dis Model Mech; 2010; 3(9-10):517-23. PubMed ID: 20354112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systems biology of tumor dormancy: linking biology and mathematics on multiple scales to improve cancer therapy.
    Enderling H; Hahnfeldt P; Hlatky L; Almog N
    Cancer Res; 2012 May; 72(9):2172-5. PubMed ID: 22414579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dry computational approaches for wet medical problems.
    Emmert-Streib F; Zhang SD; Hamilton P
    J Transl Med; 2014 Jan; 12():26. PubMed ID: 24460894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report on EU-USA workshop: how systems biology can advance cancer research (27 October 2008).
    Aebersold R; Auffray C; Baney E; Barillot E; Brazma A; Brett C; Brunak S; Butte A; Califano A; Celis J; Cufer T; Ferrell J; Galas D; Gallahan D; Gatenby R; Goldbeter A; Hace N; Henney A; Hood L; Iyengar R; Jackson V; Kallioniemi O; Klingmüller U; Kolar P; Kolch W; Kyriakopoulou C; Laplace F; Lehrach H; Marcus F; Matrisian L; Nolan G; Pelkmans L; Potti A; Sander C; Seljak M; Singer D; Sorger P; Stunnenberg H; Superti-Furga G; Uhlen M; Vidal M; Weinstein J; Wigle D; Williams M; Wolkenhauer O; Zhivotovsky B; Zinovyev A; Zupan B
    Mol Oncol; 2009 Feb; 3(1):9-17. PubMed ID: 19383362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer systems biology in the genome sequencing era: part 2, evolutionary dynamics of tumor clonal networks and drug resistance.
    Wang E; Zou J; Zaman N; Beitel LK; Trifiro M; Paliouras M
    Semin Cancer Biol; 2013 Aug; 23(4):286-92. PubMed ID: 23792107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics and systems biology of cancers.
    Omenn GS
    Prog Mol Biol Transl Sci; 2010; 95():159-91. PubMed ID: 21075332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer systems biology in the genome sequencing era: part 1, dissecting and modeling of tumor clones and their networks.
    Wang E; Zou J; Zaman N; Beitel LK; Trifiro M; Paliouras M
    Semin Cancer Biol; 2013 Aug; 23(4):279-85. PubMed ID: 23791722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preface on application of omics technologies in cancer biology and therapy.
    Georgakilas AG
    Cancer Lett; 2016 Nov; 382(1):A1. PubMed ID: 27765153
    [No Abstract]   [Full Text] [Related]  

  • 11. Electronic health records (EHRs): supporting ASCO's vision of cancer care.
    Yu P; Artz D; Warner J
    Am Soc Clin Oncol Educ Book; 2014; ():225-31. PubMed ID: 24857080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer.
    Ballestrero A; Bedognetti D; Ferraioli D; Franceschelli P; Labidi-Galy SI; Leo E; Murai J; Pommier Y; Tsantoulis P; Vellone VG; Zoppoli G
    J Transl Med; 2017 Oct; 15(1):199. PubMed ID: 28969705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer genome explosion and systems biology: impact on surgical oncology?
    Roukos DH
    Ann Surg Oncol; 2011 Jan; 18(1):12-5. PubMed ID: 20890728
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical proteomics in cancer: Where we are.
    Panis C; Pizzatti L; Souza GF; Abdelhay E
    Cancer Lett; 2016 Nov; 382(2):231-239. PubMed ID: 27561426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From oncogene to network addiction: the new frontier of cancer genomics and therapeutics.
    Tonon G
    Future Oncol; 2008 Aug; 4(4):569-77. PubMed ID: 18684067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers of oxidative stress and cancer: from chemistry, biology to clinical applications and personalized therapy.
    Georgakilas AG; Panayiotidis MI
    Curr Mol Med; 2012 Jul; 12(6):653-4. PubMed ID: 22303842
    [No Abstract]   [Full Text] [Related]  

  • 17. Computational approaches in cancer multidrug resistance research: Identification of potential biomarkers, drug targets and drug-target interactions.
    Tolios A; De Las Rivas J; Hovig E; Trouillas P; Scorilas A; Mohr T
    Drug Resist Updat; 2020 Jan; 48():100662. PubMed ID: 31927437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network pharmacology of cancer: From understanding of complex interactomes to the design of multi-target specific therapeutics from nature.
    Poornima P; Kumar JD; Zhao Q; Blunder M; Efferth T
    Pharmacol Res; 2016 Sep; 111():290-302. PubMed ID: 27329331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomes and cancer: From oncogenic roles to therapeutic applications.
    Mohammadi S; Yousefi F; Shabaninejad Z; Movahedpour A; Mahjoubin Tehran M; Shafiee A; Moradizarmehri S; Hajighadimi S; Savardashtaki A; Mirzaei H
    IUBMB Life; 2020 Apr; 72(4):724-748. PubMed ID: 31618516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer genomics identifies determinants of tumor biology.
    Mardis ER
    Genome Biol; 2010; 11(5):211. PubMed ID: 20441611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.